Table 1 Demographic characteristics of the Participants
From: Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
Characteristic | Allergic diseases (n = 381) | Control group (n = 1545) |
|---|---|---|
Age, y | 35.1 (9.4) | 36.7 (11.1) |
Sex | ||
Female | 276 (72.4) | 969 (62.7) |
Male | 105 (27.6) | 576 (37.3) |
Comorbidities | ||
Hypertension | 19 (5.0) | 75 (4.9) |
Diabetes mellitus | 2 (0.5) | 13 (0.8) |
Chronic gastritis | 7 (1.8) | 5 (0.3) |
Hyperthyroidism | 0 | 5 (0.3) |
Hypothyroidism | 2 (0.5) | 5 (0.3) |
Others | 2 (0.5) | 17 (1.1) |
Allergic status | ||
Asthma | 15 (3.9) | |
Allergic rhinitis | 236 (61.9) | |
Atopic dermatitis | 37 (9.7) | |
Eczema | 58 (15.2) | |
Urticaria | 86 (22.6) |